Skip to main content

Table 2 The combination of ADA and TL status

From: Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

 

Normal TL

Low TL

ADA negative

58%

21.4%

ADA positive

10.7%

9.8%

  1. (ADA Anti-drug antibody, TL Trough level)
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us